Emergent Biosolutions: Credit Suisse Antibody Day (Emergent Biosolutions) - May 10, 2013 - Anticipated presentation of data from P1b/2 trial for relapsed chronic lymphocytic leukemia at ASH (Dec 07-10, 2013); Anticipated presentation of data from P1b trial for first-line chronic lymphocytic leukemia at ASH (Dec 07-10, 2013)
Anticipated P1 data • Anticipated P1/2 data • Hematological Malignancies • Non-Hodgkin's Lymphoma
|